1832 Asset Management L.P. Biogen Inc. Transaction History

1832 Asset Management L.P.

$52.5 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $1,266 - $1,429	5 New	5 $1,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $6.95 Million - $9.58 Million	35,700 New	35,700 $9.53 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1,875 - $2,230	-10 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $242,281 - $311,367	-1,082 Reduced 99.08%	10 $2,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $309,025 - $403,002	1,092 New	1,092 $314,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $11.3 Million - $15 Million	-43,700 Closed	0 $0
Q1 2020 May 26, 2020	BUY	$268.85 - $341.04 $11.7 Million - $14.9 Million	43,700 New	43,700 $13.9 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $978,480 - $1.1 Million	-4,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $980,884 - $1.08 Million	4,473 Added 16566.67%	4,500 $1.08 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $4,767 - $7,457	22 Added 440.0%	27 $6,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $9.09 Million - $11.5 Million	-32,626 Reduced 99.98%	5 $2,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $3.75 Million - $4.9 Million	12,771 Added 64.31%	32,631 $11.4 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $8.21 Million - $9.78 Million	-31,874 Reduced 61.61%	19,860 $5.74 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.85 Million - $4.03 Million	-10,966 Reduced 17.49%	51,734 $14 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $31.1 Million - $34.9 Million	-101,186 Reduced 61.74%	62,700 $19.8 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $46.1 Million - $54 Million	163,886	163,886 $49.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account